Purpose-Built Informatics Solution for Cannabis Testing Previews at 2018 Cannabis Science Conference
LabVantage’s purpose-built solution bundles its leading LIMS software with unique features tailored to industry-specific needs
LabVantage’s purpose-built solution bundles its leading LIMS software with unique features tailored to industry-specific needs
ACD/Labs algorithms will continue to equip ChemSpider with physicochemical property values and chemical nomenclature following ten-year milestone
Gently compressed stacks of graphene form sharp crinkles that carry an electric charge, which could be useful in nanoscale self-assembly and other applications
SelectScience will be attending the AACC Annual Meeting in Chicago, USA, to interview leading scientists and report on the latest technologies
Agreement focuses on an innovative mobile testing solution for in-field analysis of lubricating oils and greases
By partnering with WCRF, SCIEX supports research that benefits cancer patients
Agreement to focus on accelerating campus innovation from lab to real world via UCI Applied Innovation
University of Missouri School of Medicine pilots Roche’s cloud-based NAVIFY Tumor Board solution to streamline & standardize data collection and presentation, enabling faster, better collaboration among oncology care teams
Osaka University researchers design organic photovoltaic polymer using machine learning
Beckman Coulter Diagnostics launches software version 2 - enhancements improve flagging and streamline the quality control processes
The highly anticipated platform was launched by Repositive at AACR annual meeting
New Synapsys microbiology informatics solution will be demonstrated at the event
During the American Association for Cancer Research 2018 Annual Meeting, SelectScience recognized cutting-edge products and technologies advancing life sciences research
The trial demonstrates that first-line pembrolizumab treatment improved overall and progression-free survival rates in patients with metastatic nonsquamous non-small cell lung cancer
The primary endpoint for first-line nivolumab-ipilimumab combo trial indicates improved progression-free survival in patients with advanced non-small cell lung cancer
Expansion of circulating tumor-specific T cells after nivolumab treatment suggests systemic antitumor immunity in patients with resectable lung cancer
A recent study from University of Edinburgh aims to pinpoint genes that may be associated with depression